Novavax

74,187

$105.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$9.96 (+10.56%) Today
+$1.18 (+1.13%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Novavax and other stocks, options, ETFs, and crypto commission-free!

About NVAX

Novavax, Inc. Common Stock, also called Novavax, is operates as a clinical-stage biotechnology company, which focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. Read More It produces vaccine candidates to respond to both known and emerging disease threats by using the proprietary recombinant nanoparticle vaccine technology. The firm's vaccine candidates include ResVax and NanoFlu. It also develops immune stimulating saponin-based adjuvants through its wholly owned Swedish subsidiary, Novavax AB. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Employees
165
Headquarters
Gaithersburg, Maryland
Founded
1987
Market Cap
6.05B
Price-Earnings Ratio
Dividend Yield
Average Volume
9.82M
High Today
$113.98
Low Today
$95.26
Open Price
$95.33
Volume
8.64M
52 Week High
$113.98
52 Week Low
$3.54

Collections

NVAX News

MarketWatchJul 7

Novavax's 30% surge boosts biotech ETFs to best day in weeks

Exchange-traded funds with exposure to biotech stocks rocketed higher Tuesday on hopeful news about treatments for COVID-19. The ETFMG Treatments, Testing and A
0
BenzingaJul 7

Novavax CEO Talks $1.6B Federal Funding Win, Ex-FDA Chief Says It's A 'Good Bet'

The U.S. government awarded Novavax, Inc. (NASDAQ: NVAX) $1.6 billion in funding to support its COVID-19 vaccine, and the company is confident it has the capabi
0
BenzingaJul 7

Novavax Shares Cross $100 Threshold On $1.6B Federal Funding Award For Coronavirus Vaccine

Novavax, Inc. (NASDAQ: NVAX) shares, which were up about 1,900% year-to-date, are seeing further strength after the company's coronavirus vaccine program was sh
0

NVAX Earnings

-$1.69
-$1.13
-$0.56
$0.00
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
per share
Actual
Expected Aug 5, After Hours

You May Also Like

More NVAX News

BloombergJul 7

Novavax Covid Vaccine Gets $1.6 Billion in U.S. Funding

(Bloomberg) -- Novavax Inc., one of the front-runners in the race to develop a Covid-19 vaccine, will receive $1.6 billion from the U.S. government, the biggest
0
CNBCJul 7

Stocks making the biggest moves in the premarket: Novavax, Regeneron, Square, Nvidia & more

Take a look at some of the biggest movers in the premarket: Novavax (NVAX) – Novavax was awarded $1.6 billion in funding from "Operation Warp Speed," the gover
0
ReutersJul 7

BRIEF-Novavax Announces $1.6 Billion Funding From Operation Warp Speed

July 7 (Reuters) - Novavax Inc: * NOVAVAX ANNOUNCES $1.6 BILLION FUNDING FROM OPERATION WARP SPEED * NOVAVAX INC - OWS AWARD FUNDS LARGE-SCALE MANUFACTURING O
0
MarketWatchJul 7

Novavax shares soar 38% premarket on news of $1.6 billion in funding for COVID-19 vaccine candidate

Novavax Inc. NVAX, -2.69% said Tuesday it has received $1.6 billion in funding from the federal government's accelerated COVID-19 vaccine development program "O
0
ReutersJul 7

U.S. government awards Novavax $1.6 billion for coronavirus vaccine

By Julie Steenhuysen CHICAGO (Reuters) - The U.S. government has awarded Novavax Inc $1.6 billion to cover testing and manufacturing of a potential vaccine for
0
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.